Clinical Trial Update: PED NEONAT 20-000599 Fetal Body Composition [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on fetal body composition (PED NEONAT 20-000599) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus
• Intrauterine Growth Restriction
• Pregnancy-related Conditions

Snippet

Sponsor: University of California, Los Angeles | Conditions: IUGR, Gestational Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2023-08-30